Cargando…
Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)
We herein report the identification of an HLA-A2 supertype-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2), which is known to be a diagnostic marker and a potential therapeutic target for renal cell carcinoma. Among several candidate peptides predicted by the HLA-binding p...
Autores principales: | Yoshimura, Sachiko, Tsunoda, Takuya, Osawa, Ryuji, Harada, Makiko, Watanabe, Tomohisa, Hikichi, Tetsuro, Katsuda, Masahiro, Miyazawa, Motoki, Tani, Masaji, Iwahashi, Makoto, Takeda, Kazuyoshi, Katagiri, Toyomasa, Nakamura, Yusuke, Yamaue, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885709/ https://www.ncbi.nlm.nih.gov/pubmed/24416375 http://dx.doi.org/10.1371/journal.pone.0085267 |
Ejemplares similares
-
Identification of HLA-A24-Restricted Novel T Cell Epitope Peptides Derived from P-Cadherin and Kinesin Family Member 20A
por: Osawa, Ryuji, et al.
Publicado: (2012) -
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma
por: Obara, Wataru, et al.
Publicado: (2016) -
Antitumor Effects of Interleukin‐2 Gene‐modified Fibroblasts in an Orthotopic Colon Cancer Model
por: Terasawa, Hiroshi, et al.
Publicado: (1999) -
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
por: Mao, Xing-gang, et al.
Publicado: (2016) -
Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice
por: Hayata, Keiji, et al.
Publicado: (2013)